Viking Therapeutics, Inc.(VKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VKTX Viking Therapeutics, Inc.

交易中 07-30 14:10:44 EDT

34.21

+1.30

+3.95%

最高34.40	最低33.13	成交量197.15万
今开33.25	昨收32.91	日振幅3.87%
总市值38.47亿	流通市值37.63亿	总股本1.12亿
成交额6,696万	换手率1.79%	流通股本1.10亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VKTX","market":"US","secType":"STK","nameCN":"Viking Therapeutics, Inc.","latestPrice":34.21,"timestamp":1753899032890,"preClose":32.91,"halted":0,"volume":1971546,"delay":0,"floatShares":109982573,"shares":112444961,"eps":-1.536798,"marketStatus":"交易中","change":1.3,"latestTime":"07-30 14:10:44 EDT","open":33.25,"high":34.4,"low":33.125,"amount":66963829.991802,"amplitude":0.038742,"askPrice":34.23,"askSize":100,"bidPrice":34.17,"bidSize":24,"shortable":3,"etf":0,"ttmEps":-1.536798,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1753905600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1430280000000,"exchange":"NASDAQ","adjPreClose":32.91,"preHourTrading":{"tag":"盘前","latestPrice":33.28,"preClose":32.91,"latestTime":"09:29 EDT","volume":10715,"amount":353454.09774999996,"timestamp":1753882151954},"postHourTrading":{"tag":"盘后","latestPrice":32.8,"preClose":32.91,"latestTime":"19:54 EDT","volume":49466,"amount":1626650.1604,"timestamp":1753833246204},"volumeRatio":0.515993,"impliedVol":1.1181,"impliedVolPercentile":0.836},"requestUrl":"/m/hq/s/VKTX","defaultTab":"news","newsList":[{"id":"1188474416","title":"维京2025财年Q2业绩会总结及问答精华：肥胖治疗新药进展显著","url":"https://stock-news.laohu8.com/highlight/detail?id=1188474416","media":"业绩会速递","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188474416?lang=zh_cn&edition=full","pubTime":"2025-07-24 18:32","pubTimestamp":1753353135,"startTime":"0","endTime":"0","summary":"未来计划包括继续推进VK2735的3期临床试验，并在2025年第四季度提交针对淀粉样受体激动剂项目的新药研究申请。净亏损为6560万美元，每股亏损0.58美元，而去年同期净亏损为2230万美元，每股亏损0.20美元。问题4：在3期Vanquish试验中，您有一个17.5毫克的最高剂量。此外，安慰剂组患者在试验结束后有资格进入开放标签延长期。我们计划在今年第四季度向FDA提交IND申请。维京公司在2025财年第二季度取得了显著进展，特别是在VK2735肥胖治疗项目的临床试验中。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VKTX"],"gpt_icon":1},{"id":"2553320517","title":"Viking Therapeutics, Inc.2025财年第二财季实现净利润-65.56百万美元，同比减少194.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553320517","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553320517?lang=zh_cn&edition=full","pubTime":"2025-07-24 17:00","pubTimestamp":1753347625,"startTime":"0","endTime":"0","summary":"7月24日，Viking Therapeutics, Inc.公布财报，公告显示公司2025财年第二财季净利润为-65.56百万美元，同比减少194.65%；其中营业收入为0.00美元，每股基本收益为-0.58美元。从资产负债表来看，Viking Therapeutics, Inc.总负债32.39百万美元，其中短期债务468000.00美元，资产负债比为0.26，流动比率为0.26。机构评级：截至2025年7月24日，当前有19家机构对Viking Therapeutics, Inc.目标价做出预测，其中目标均价为89.58美元，其中最低目标价为30.00美元，最高目标价为125.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724172632a460fdbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724172632a460fdbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VKTX","LENZ"],"gpt_icon":0},{"id":"1136970098","title":"异动解读 | Viking Therapeutics盘前大跌8.2%，季度亏损远超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1136970098","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136970098?lang=zh_cn&edition=full","pubTime":"2025-07-24 16:14","pubTimestamp":1753344865,"startTime":"0","endTime":"0","summary":"生物制药公司Viking Therapeutics, Inc.今日盘前大跌8.2%，主要受到公司最新季度财报不及预期的影响。这一跌幅远超昨日夜盘5.36%的跌幅，反映出投资者对公司财务状况的担忧程度进一步加深。根据公司公布的财报，截至6月30日的季度，Viking Therapeutics调整后每股亏损为58美分，远超分析师平均预期的45美分亏损。尽管Viking Therapeutics在生物技术领域有着潜力巨大的研发管线，但持续的巨额亏损引发了投资者对公司短期财务状况的担忧。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VKTX"],"gpt_icon":0},{"id":"1131694288","title":"异动解读 | Viking Therapeutics季度亏损超预期，夜盘股价大跌5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131694288","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131694288?lang=zh_cn&edition=full","pubTime":"2025-07-24 08:02","pubTimestamp":1753315372,"startTime":"0","endTime":"0","summary":"生物制药公司Viking Therapeutics, Inc.在夜盘交易中股价大跌5.36%，引发投资者关注。这一跌幅主要受到公司最新季度财报不及预期的影响。根据公司公布的财报，截至6月30日的季度，Viking Therapeutics调整后每股亏损为58美分，远超分析师平均预期的45美分亏损。尽管Viking Therapeutics在生物技术领域有着潜力巨大的研发管线，包括VK2809、VK5211和VK0214等产品，但持续的巨额亏损似乎引发了投资者对公司短期财务状况的担忧。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VKTX"],"gpt_icon":0},{"id":"1153521511","title":"这些美股股票本周或随财报发布而大幅波动","url":"https://stock-news.laohu8.com/highlight/detail?id=1153521511","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153521511?lang=zh_cn&edition=full","pubTime":"2025-07-22 12:00","pubTimestamp":1753156846,"startTime":"0","endTime":"0","summary":"第二季度财报季似乎开局良好，标普500指数成分股中已有12%发布财报。展望未来，这些股票本周可能因最新季度业绩而表现突出的股票，具体通过分析期权市场活动预测其潜在波动幅度。这家休闲快餐卷饼连锁店将于本周三公布业绩，股价可能因此波动6%。西南航空该股年内上涨10%，本周三公布最新季度财报后股价可能波动5%，公司将于次日召开财报电话会议。$特许通讯 $这家电信公司股价今年上涨13%，财报公布后（本周五）可能波动7%。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/61928afb8d779fedee3e8c2bb8802198","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/61928afb8d779fedee3e8c2bb8802198"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["T","GOOGL","DECK","LUV","GM","VKTX","URI","INTC","DHR","ENPH"],"gpt_icon":1},{"id":"2537474596","title":"Viking Therapeutics, Inc.盘中异动 下午盘急速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537474596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537474596?lang=zh_cn&edition=full","pubTime":"2025-05-21 02:04","pubTimestamp":1747764242,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日02时04分，Viking Therapeutics, Inc.股票出现异动，股价急速上涨5.02%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。公司临床方案管线包括VK2809、VK5211、VK0214产品。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521020402a485b59f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521020402a485b59f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","VKTX","LENZ","BK4007","BK4588","BK4139","BK4599","BK4585"],"gpt_icon":0},{"id":"2536638459","title":"Viking Therapeutics, Inc.盘中异动 急速跳水5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536638459","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536638459?lang=zh_cn&edition=full","pubTime":"2025-05-19 22:29","pubTimestamp":1747664949,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日22时29分，Viking Therapeutics, Inc.股票出现波动，股价大幅下跌5.17%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Polyrizon Ltd.、Protagenic Therapeutics, Inc.、Nucana Plc较为活跃，换手率分别为8638.81%、6060.92%、2364.45%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、Brainstorm Cell Therapeutics Inc.，振幅分别为330.19%、81.85%、31.82%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051922291094fb9dc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051922291094fb9dc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4588","BK4585","BK4139","VKTX","BK4599","BK4007"],"gpt_icon":0},{"id":"2535313066","title":"Viking Therapeutics, Inc.盘中异动 早盘快速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535313066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535313066?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:46","pubTimestamp":1747403195,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时46分，Viking Therapeutics, Inc.股票出现异动，股价大幅上涨5.00%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Affimed N.V.、Inozyme Pharma, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Affimed N.V.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为1748.29%、1500.50%、838.29%，振幅较大的相关个股有Affimed N.V.、Pasithea Therapeutics Corp.、Vor Biopharma Inc.，振幅分别为404.58%、32.54%、27.79%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516214635aa2c9138&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516214635aa2c9138&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VKTX","BK4588","BK4139","BK4539","LENZ","BK4599","BK4585"],"gpt_icon":0},{"id":"2535873009","title":"Viking Therapeutics, Inc.盘中异动 急速跳水5.01%报26.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535873009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535873009?lang=zh_cn&edition=full","pubTime":"2025-05-15 02:20","pubTimestamp":1747246824,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日02时20分，Viking Therapeutics, Inc.股票出现异动，股价急速跳水5.01%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.16%。其相关个股中，Klotho Neurosciences, Inc.、Onconetix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Polyrizon Ltd.、Nucana Plc、Klotho Neurosciences, Inc.较为活跃，换手率分别为4822.47%、4603.60%、1719.66%，振幅较大的相关个股有Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Onconetix, Inc.，振幅分别为339.54%、202.60%、135.53%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515022024a47e7c38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515022024a47e7c38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VKTX","BK4588","BK4585","BK4539","LENZ","BK4599","BK4139"],"gpt_icon":0},{"id":"2533597136","title":"Viking Therapeutics, Inc.盘中异动 快速跳水5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533597136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533597136?lang=zh_cn&edition=full","pubTime":"2025-05-06 23:39","pubTimestamp":1746545962,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日23时39分，Viking Therapeutics, Inc.股票出现异动，股价急速跳水5.10%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为4.57%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Liminatus Pharma Inc C/Wts 30/04/2030 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Pasithea Therapeutics Corp.、Galmed Pharmaceuticals Ltd.、Nucana Plc较为活跃，换手率分别为7553.95%、1168.81%、450.01%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为158.45%、42.31%、39.52%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506233922a47430c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506233922a47430c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4588","VKTX","LENZ","BK4139","BK4585","BK4007"],"gpt_icon":0},{"id":"2532825366","title":"Viking Therapeutics, Inc.盘中异动 快速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532825366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532825366?lang=zh_cn&edition=full","pubTime":"2025-05-02 22:42","pubTimestamp":1746196941,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日22时42分，Viking Therapeutics, Inc.股票出现异动，股价急速上涨5.01%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。该信息摘要如下：Viking Therapeutics获坎托菲茨杰拉德公司首次覆盖，给予增持评级, 目标价104.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502224221a4701058&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502224221a4701058&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VKTX","BK4599","BK4588","LENZ","BK4007","BK4585"],"gpt_icon":0},{"id":"2531737572","title":"Viking Therapeutics, Inc.盘中异动 股价大涨5.36%报27.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531737572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531737572?lang=zh_cn&edition=full","pubTime":"2025-04-29 21:31","pubTimestamp":1745933467,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时31分，Viking Therapeutics, Inc.股票出现异动，股价快速拉升5.36%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.78%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。该信息摘要如下：Viking Therapeutics获坎托菲茨杰拉德公司首次覆盖，给予增持评级, 目标价104.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042921310794e79b11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042921310794e79b11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VKTX","LENZ","BK4007","BK4585","BK4588","BK4599"],"gpt_icon":0},{"id":"2531269193","title":"Viking Therapeutics(VKTX.US)获坎托菲茨杰拉德公司首次覆盖，给予增持评级, 目标价104.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531269193","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531269193?lang=zh_cn&edition=full","pubTime":"2025-04-29 04:51","pubTimestamp":1745873463,"startTime":"0","endTime":"0","summary":"Viking Therapeutics(VKTX.US)获坎托菲茨杰拉德公司首次覆盖，给予增持评级, 目标价104.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/29045149977047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VKTX","LENZ"],"gpt_icon":0},{"id":"2530228954","title":"Viking Therapeutics, Inc.盘中异动 急速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530228954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530228954?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:43","pubTimestamp":1745847819,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时43分，Viking Therapeutics, Inc.股票出现波动，股价大幅拉升5.04%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Galmed Pharmaceuticals Ltd.、Cg Oncology, Inc.、Portage Biotech Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Tharimmune, Inc.较为活跃，换手率分别为1597.19%、344.10%、66.30%，振幅较大的相关个股有Galmed Pharmaceuticals Ltd.、Protara Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为27.39%、22.69%、22.50%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428214340a6cbc313&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428214340a6cbc313&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4588","VKTX","LENZ","BK4139","BK4585","BK4007"],"gpt_icon":0},{"id":"2530410159","title":"Viking Therapeutics, Inc.2025财年第一财季实现净利润-45.63百万美元，同比减少66.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530410159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530410159?lang=zh_cn&edition=full","pubTime":"2025-04-25 23:01","pubTimestamp":1745593260,"startTime":"0","endTime":"0","summary":"4月25日，Viking Therapeutics, Inc.公布财报，公告显示公司2025财年第一财季净利润为-45.63百万美元，同比减少66.78%；其中营业收入为0.00美元，每股基本收益为-0.41美元。从资产负债表来看，Viking Therapeutics, Inc.总负债20.08百万美元，其中短期债务498000.00美元，资产负债比为0.44，流动比率为0.45。机构评级：截至2025年4月25日，当前有18家机构对Viking Therapeutics, Inc.目标价做出预测，其中目标均价为89.50美元，其中最低目标价为30.00美元，最高目标价为125.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425230103a466f50a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425230103a466f50a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VKTX","LENZ"],"gpt_icon":0},{"id":"2530132873","title":"Viking Therapeutics, Inc.盘中异动 早盘大幅下挫5.03%报24.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530132873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530132873?lang=zh_cn&edition=full","pubTime":"2025-04-25 21:55","pubTimestamp":1745589310,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日21时55分，Viking Therapeutics, Inc.股票出现波动，股价快速下挫5.03%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.16%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。该信息摘要如下：大摩：维持Viking Therapeutics评级，由增持调整至增持评级, 目标价由105.00美元调整至102.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425215510a466e83e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425215510a466e83e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4585","VKTX","BK4588","LENZ","BK4599","BK4139"],"gpt_icon":0},{"id":"2530096501","title":"大摩：维持Viking Therapeutics评级，由增持调整至增持评级, 目标价由105.00美元调整至102.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2530096501","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530096501?lang=zh_cn&edition=full","pubTime":"2025-04-25 01:15","pubTimestamp":1745514947,"startTime":"0","endTime":"0","summary":"大摩：维持Viking Therapeutics(VKTX.US)评级，由增持调整至增持评级, 目标价由105.00美元调整至102.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504250117529743e1cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504250117529743e1cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VKTX","LENZ"],"gpt_icon":0},{"id":"2529535074","title":"Viking Therapeutics, Inc.盘中异动 快速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529535074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529535074?lang=zh_cn&edition=full","pubTime":"2025-04-22 23:32","pubTimestamp":1745335945,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日23时32分，Viking Therapeutics, Inc.股票出现异动，股价急速拉升5.02%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.80%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422233225a462a4e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422233225a462a4e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4007","LENZ","BK4585","BK4599","VKTX"],"gpt_icon":0},{"id":"2527435449","title":"Viking Therapeutics, Inc.盘中异动 股价大跌5.01%报23.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527435449","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527435449?lang=zh_cn&edition=full","pubTime":"2025-04-15 23:03","pubTimestamp":1744729396,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日23时03分，Viking Therapeutics, Inc.股票出现异动，股价急速下跌5.01%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Mural Oncology Plc、Dogwood Therapeutics, Inc.、Skye Bioscience, Inc.涨幅较大，Mural Oncology Plc、Dogwood Therapeutics, Inc.、Metavia Inc.较为活跃，换手率分别为1006.37%、726.35%、235.68%，振幅较大的相关个股有Skye Bioscience, Inc.、Dogwood Therapeutics, Inc.、Mural Oncology Plc，振幅分别为171.53%、91.33%、86.41%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041523031794d640c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041523031794d640c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4599","VKTX","BK4588","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"1127272877","title":"辉瑞停止减肥药Danuglipron的开发，诺和诺德等竞争对手或受益","url":"https://stock-news.laohu8.com/highlight/detail?id=1127272877","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127272877?lang=zh_cn&edition=full","pubTime":"2025-04-14 18:55","pubTimestamp":1744628104,"startTime":"0","endTime":"0","summary":"参与者出现了潜在的药物引起的肝损伤。","market":"us","thumbnail":"https://static.tigerbbs.com/2b018a2cb1bd3235e9b3fc27a303ba29","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/2b018a2cb1bd3235e9b3fc27a303ba29"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VKTX","NVO","PFE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vikingtherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0252},{"period":"1month","weight":0.241},{"period":"3month","weight":0.1399},{"period":"6month","weight":-0.0232},{"period":"1year","weight":-0.4627},{"period":"ytd","weight":-0.1822}],"compareEarnings":[{"period":"1week","weight":0.0102},{"period":"1month","weight":0.0331},{"period":"3month","weight":0.1456},{"period":"6month","weight":0.0499},{"period":"1year","weight":0.1661},{"period":"ytd","weight":0.0839}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Viking Therapeutics, Inc.于2012年9月24号在特拉华州成立。该公司是一个临床阶段的生物制药公司，致力于开发新的，第一类或最好的新陈代谢和内分泌失调类疗法。该公司拥有全球独家权利基于许可的配体小分子组合在五个候选药物在临床试验或临床前研究。公司的主导临床程序是VK0612，它是进入2b期临床试验为2型全球最大的健康挑战之一的治疗糖尿病疾病口服药物，它在同药物中排列第一。公司的第二临床程序vk5211，可把口服的候选药物送入第二阶段临床试验治疗一种复杂的疾病特点的不受控制的肌肉质量下降癌症恶病。VK5211是一种非甾体选择性雄激素受体调节剂，或SARM。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.010029},{"month":2,"riseRate":0.5,"avgChangeRate":0.226268},{"month":3,"riseRate":0.3,"avgChangeRate":-0.034371},{"month":4,"riseRate":0.5,"avgChangeRate":0.019074},{"month":5,"riseRate":0.272727,"avgChangeRate":0.07927},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.022105},{"month":7,"riseRate":0.545455,"avgChangeRate":0.017377},{"month":8,"riseRate":0.5,"avgChangeRate":0.030421},{"month":9,"riseRate":0.3,"avgChangeRate":0.062199},{"month":10,"riseRate":0.3,"avgChangeRate":0.012685},{"month":11,"riseRate":0.5,"avgChangeRate":-0.01667},{"month":12,"riseRate":0.6,"avgChangeRate":0.16221}],"exchange":"NASDAQ","name":"Viking Therapeutics, Inc.","nameEN":"Viking Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Viking Therapeutics, Inc.(VKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Viking Therapeutics, Inc.(VKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Viking Therapeutics, Inc.,VKTX,Viking Therapeutics, Inc.股票,Viking Therapeutics, Inc.股票老虎,Viking Therapeutics, Inc.股票老虎国际,Viking Therapeutics, Inc.行情,Viking Therapeutics, Inc.股票行情,Viking Therapeutics, Inc.股价,Viking Therapeutics, Inc.股市,Viking Therapeutics, Inc.股票价格,Viking Therapeutics, Inc.股票交易,Viking Therapeutics, Inc.股票购买,Viking Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Viking Therapeutics, Inc.(VKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Viking Therapeutics, Inc.(VKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}